Nano-based approach to combat emerging viral (NIPAH virus) infectionopen access
- Authors
- Kerry, Rout George; Malik, Santosh; Redda, Yisehak Tsegaye; Sahoo, Sabuj; Patra, Jayanta Kumar; Majhi, Sanatan
- Issue Date
- Jun-2019
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Nanomedicine; Diagnostics; Nipah virus; Antiviral; Virucide
- Citation
- NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, v.18, pp 196 - 220
- Pages
- 25
- Indexed
- SCIE
SCOPUS
- Journal Title
- NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
- Volume
- 18
- Start Page
- 196
- End Page
- 220
- URI
- https://scholarworks.dongguk.edu/handle/sw.dongguk/8080
- DOI
- 10.1016/j.nano.2019.03.004
- ISSN
- 1549-9634
1549-9642
- Abstract
- Emergence of new virus and their heterogeneity are growing at an alarming rate. Sudden outburst of Nipah virus (NiV) has raised serious question about their instant management using conventional medication and diagnostic measures. A coherent strategy with versatility and comprehensive perspective to confront the rising distress could perhaps be effectuated by implementation of nanotechnology. But in concurrent to resourceful and precise execution of nano-based medication, there is an ultimate need of concrete understanding of the NIV pathogenesis. Moreover, to amplify the effectiveness of nano-based approach in a conquest against NiV, a list of developed nanosystem with antiviral activity is also a prerequisite. Therefore the present review provides a meticulous cognizance of cellular and molecular pathogenesis of NiV. Conventional as well several nano-based diagnosis experimentations against viruses have been discussed. Lastly, potential efficacy of different forms of nano-based systems as convenient means to shield mankind against NiV has also been introduced. (C) 2019 Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Science and Biotechnology > ETC > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.